{"componentChunkName":"component---src-templates-news-news-template-tsx","path":"/news/biweekly-news-of-life-science-market-081220","result":{"pageContext":{"article":{"id":134,"title":"Biweekly News of Life Science Market! 08/12/20","slug":"biweekly-news-of-life-science-market-081220","article":"<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><strong style=\"\"><span style=\"color: rgb(12, 52, 61); font-size: 18px; font-family: Helvetica, sans-serif;\">News: 08/12/2020</span></strong></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2020/anvisa-define-requisitos-para-pedidos-de-uso-emergencial-de-vacinas\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"><strong><span style=\"color: rgb(12, 52, 61); text-decoration: none; font-size: 18px; font-family: Helvetica, sans-serif;\">Anvisa defines\n                requirements for requests for emergency use of vaccines</span></strong></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2020/anvisa-define-requisitos-para-pedidos-de-uso-emergencial-de-vacinas\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\">Guide prepared by\n            the Agency guides developers on procedures for authorization of emergency use\n            of vaccines against Covid-19.</span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2020/anvisa-define-requisitos-para-pedidos-de-uso-emergencial-de-vacinas\" target=\"_blank\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\"><br>\n        </span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/industria-4-0-cerca-de-86-das-empresas-esperam-reduzir-custos/\" style=\"color: blue; text-decoration: underline;\"><strong><span style=\"color: rgb(12, 52, 61); text-decoration: none; font-size: 18px; font-family: Helvetica, sans-serif;\">Industry 4.0: about 86% of companies expect to reduce\n                costs</span></strong></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/industria-4-0-cerca-de-86-das-empresas-esperam-reduzir-custos/\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\">According to a PWC survey, about 86% of companies\n            expect to reduce costs and increase profitability with industry 4.0.</span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/industria-4-0-cerca-de-86-das-empresas-esperam-reduzir-custos/\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\"><br>\n        </span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/04/no-brasil-logistica-e-o-grande-desafio-para-plano-nacional-de-vacinacao/\" style=\"color: blue; text-decoration: underline;\"><strong><span style=\"color: rgb(12, 52, 61); text-decoration: none; font-family: Helvetica, sans-serif;\">In Brazil, logistics is the big challenge for the National\n                Vaccination Plan</span></strong></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/industria-4-0-cerca-de-86-das-empresas-esperam-reduzir-custos/\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\">According to the Ministry of Health, in a\n            statement made last Tuesday (01), the national vaccination plan against\n            Covid-19 will have, at first, four phases and should serve millions of people,\n            spread throughout the country, in each of them.</span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><span style=\"font-family: Helvetica, sans-serif;\">&nbsp;</span></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/kodak-avanca-mais-um-passo-para-estrear-no-setor-farmaceutico/\" style=\"color: blue; text-decoration: underline;\"><strong><span style=\"color: rgb(12, 52, 61); text-decoration: none; font-family: Helvetica, sans-serif;\">Kodak moves one step closer to debuting in the\n                pharmaceutical industry</span></strong></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/kodak-avanca-mais-um-passo-para-estrear-no-setor-farmaceutico/\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\">Kodak has taken another step forward in\n            its attempt to enter the pharmaceutical industry. The U.S. International\n            Development Finance Corp. (DFC) pointed out that there is no irregularity and\n            conflict of interest between agency employees or misconduct, according to The\n            Wall Street Journal.</span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/kodak-avanca-mais-um-passo-para-estrear-no-setor-farmaceutico/\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\"><br>\n        </span></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"http://www.tynmagazine.com/it-a-importancia-do-gap-analysis-para-gestao-da-qualidade-nas-industrias-de-life-science/\" style=\"color: blue; text-decoration: underline;\"><strong><span style=\"color: rgb(12, 52, 61); text-decoration: none; font-family: Helvetica, sans-serif;\">IT: The importance of Gap Analysis for quality management\n                in life science industries</span></strong></a></p>\n\n<p style=\"margin-right: 0px; margin-left: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 16px;\"><a href=\"https://panoramafarmaceutico.com.br/2020/12/07/kodak-avanca-mais-um-passo-para-estrear-no-setor-farmaceutico/\" style=\"color: blue; text-decoration: underline;\"><span style=\"font-family: Helvetica, sans-serif;\">As in the process of digital\n            transformation, a trend experienced by many companies and accelerated by the\n            impacts of the Covid-19 pandemic, quality should also not be centralized and\n            managed by a single department.</span></a></p>","published":true,"createdAt":"2020-12-08T12:50:39.2696478","imageId":259,"postImage":{"id":259,"type":"Blog","fileName":"16e4241c-957b-4dbe-a554-d5641c1a8406.jpg","imageData":null,"imageUrl":"https://kivalitaapi.azurewebsites.net/resources/images/16e4241c-957b-4dbe-a554-d5641c1a8406.jpg","url":null,"imageString":null},"authorId":13,"imageData":null,"language":0,"isNews":true,"isLegislation":false,"linkId":133,"translateSlug":"noticias-do-mercado-de-life-science-081220"}}},"staticQueryHashes":["4202924991"]}